Marine microalgae have been prominently featured in cancer research. Here, we examined cytotoxic effect and apoptosis mechanism of crude ethanol extracts of an indigenous microalga, Chaetoceros calcitrans (UPMAAHU10) on human breast cell lines. MCF-7 was more sensitive than MCF-10A with IC50 value of 3.00 ± 0.65, whilst the IC50 value of Tamoxifen against MCF-7 was 12.00 ± 0.52 g/mL a�er 24 hour incubation. Based on Annexin V/Propidium iodide and cell cycle �ow cytometry analysis, it was found that inhibition of cell growth by EEC on MCF-7 cells was through the induction of apoptosis without cell cycle arrest. e apoptotic cells at subG0/G1 phase in treated MCF-7 cells at 48 and 72 hours showed 34 and 16 folds increased compared to extract treated MCF-10A cells which showed only 6 and 7 folds increased at the same time points, respectively. Based on GeXP study, EEC induced apoptosis on MCF-7 cells via modulation of CDK2, MDM2, p21Cip1, Cyclin A2, Bax and Bcl-2. e EEC treated MCF-7 cells also showed an increase in Bax/Bcl-2 ratio that in turn activated the caspase-dependent pathways by activating caspase 7. us, marine microalga, Chaetoceros calcitrans may be considered a good candidate to be developed as a new anti-breast cancer drug.
Introduction
Breast cancer is the most prevalent cancer in the world (22% of all the cases) and causes the highest percentage of the cancer deaths (14% of all cancer deaths) in women worldwide. In fact, it is the most common female cancer in both developing and developed countries [1] . ere are different options of treatment for breast cancer like surgery, radiation therapy, hormone therapy, chemotherapy, and targeted therapy but these therapies are also associated with some serious side effects. Algae have been widely used by millions of humans and animals around the world as nutritional or pharmaceutical ingredient. Many studies have shown that some algae contain various biologically active substances with potential therapeutic applications in humans [2] .Due to the diverse structural forms and biological activities of marine microalgae, they can be used as a valuable source of molecules for new drug development, including novel anticancer compounds [3] . Indigenous microalgae from Malaysia such as Chaetoceros calcitrans have been shown to be potential sources of high-value chemicals including polyunsaturated fatty acids, carotenoids, phycocyanin, and phycoerythrin. All of these active ingredients indicate that such microalgae are a potential source of natural antioxidant and may show anti-in�ammatory and cytotoxic effects [4] . is study was aimed to illustrate the cytotoxic and apoptosis effects of ethanol crude extract of an indigenous microalga, Chaetoceros calcitrans, (EEC) in human breast cell line, MCF-7. We have further measured the changes of apoptotic related genes such as Bax, Bcl-2, BCL2L1, TNF, P53, Fas, Casp3, Casp7, and Casp9 and cell cycle related genes such as P21, Cyclin A2, CDK2, and MDM2 using GeXP assay. Based on the result in this study, microalgae possessed the potential as sources of anticancer agent.
Materials and Methods

Microalgae Strain and Culturing of Chaetoceros calcitrans.
A pure culture of an indigenous microalga Chaetoceros calcitrans (UPMAAHU10) was cultured in 250 to 500 mL of Conway media incubated at ambient temperature of 24 ± 2 ∘ C under constant light of 120 mol photons m 2 sec −1 in an automatic oscillating shaker at 110 rpm. Meanwhile, cultures of 5 litters were maintained in �asks at similar condition with aeration.
Preparation of Microalgae Extract.
Microalga culture reaching stationary phase (6-7 days) was harvested by centrifugation at 3500 rpm for 8 min. Resulting pellets were washed with 0.5 M ammonium formate (Sigma-Aldrich, USA) to remove excess salt. Concentrated microalgae cells were collected and dried in 40 ∘ C incubator for 3 days. e cells were homogenized with 100% ethanol (Sigma-Aldrich, USA) for 4 days. Aer that, the supernatant was �ltered using �lter cotton and 0.2 m �ltration unit (Millipore, Bedford, Japan). Supernatant was then rotary evaporated under reduced pressure at 30 ∘ C (Buchi Rotavapor R 200; Buchi Labortechnik, Flawil, Switzerland) to remove all the ethanol, as described by Lee et al. [5] . e extracts were weighted and mixed with DMSO and kept in −20 ∘ c until further use.
Cell
Cultures. e MCF-7 cells were cultured in DMEM medium with L-glutamine (Gibco, USA), supplemented with 10% (v/v) fetal bovine serum (FBS) and Penicillin (100 U/mL)/Streptomycin (100 U/mL), (Gibco, USA). e MCF-10A cells were maintained with DMEM-F12 medium, (Gibco, USA), supplemented with 10% FBS, HEPS, Glutamine, and Penicillin (100 U/mL)/Streptomycin (100 U/mL), (Gibco, USA). For the preparation of peripheral blood mononuclear cells (PBMC), 10 mL of whole blood from healthy individual were taken by using a 10 mL single-use syringe (Omni�x, Germany), mixed, and diluted with the same volume of phosphate buffer saline (PBS). Samples were centrifuged on Ficoll-Paque Plus (Amersham Biosciences, USA) at 400 ×g for 40 minutes. Interface containing lymphocytes were collected, washed, and pelleted down with PBS. Finally, the supernatant was removed and the pellet was mixed with 2 mL RPMI-1640 media with 10% fetal bovine serum (FBS). e trypan blue dye (SigmaAldrich, USA) exclusion assay was performed to determine cell number and viability.
Cytotoxic Assay (MTT Assay)
. Cytotoxicity effect of EEC was determined by MTT assay, as previously described by Mosmann [6] . Brie�y, MTT solution (Sigma-Aldrich, USA) was dissolved in PBS at 5 mg/mL. Twenty L of 5 g/mL MTT solutions was added directly to all appropriate wells. Cells were plated in 96-well plates at an initial density of and higher IC50 (3.50 g/mL) concentrations. e cells at a density of 2.5 × 10 5 cells/mL were transferred to 1.5 mL centrifuge tube and spun down at 400 × g for 5 minutes at room temperature. e supernatant was discarded and the pellet was incubated in 25 L of Solution A (trypsin buffer) for 10 minutes at room temperature. en, 200 L of Solution B (trypsin inhibitor and RNase buffer) was added to each tube and incubated for 10 minutes at room temperature. Aer that 200 L of cold Solution C (propidium iodide stain solution) was added to each tube and gently mixed by tapping the tube by hand, incubated for 10 minutes in the dark at 4 ∘ C. Aer �ltration the samples through 50 L nylon mesh were analyzed by �ow cytometry (BD FACSCalibur, USA). Each sample was tested in triplicate and untreated MCF-7 cells were used as controls.
2.7.
Cell Cycle Analysis. MCF-7 and MCF-10A cells were incubated with EEC at IC50 concentration for 24, 48, and 72 hours. e cells were then harvested by trypsinization, washed with PBS, and sub�ected to �ow cytometry analysis according to the manufacturer's recommendation (BD CycleTEST PLUS DNA Reagent Kit). Brie�y, cell pellets were �xed with 500 L iced cold 80% ethanol and kept at −20 ∘ C for 2 hours. e cells were washed twice with PBS, dissolved, and stained in 1 mL PBS buffer containing 0.1% triton X-100, 10 mM EDTA, 50 g/mL RNase, and 2 g/mL propidium iodide. e cells were then incubated for 30 minutes at 4 ∘ C and were analyzed with �ow cytometer (BD FACSCalibur, USA) within 24 hours. Each sample was tested in triplicates and untreated MCF-7 and MCF-10A cells were used as controls.
RNA Extraction.
RNA was extracted from the treated and untreated cell lines by using the RNeasy Mini Kit (Qiagen, USA) according to the manufacturer's instructions. 
Primer Designing.
Primers for a total of 13 target genes, 1 internal control and 2 house-keeping genes were designed using GenomeLab eXpress Pro�ler soware (Table 1) . Fragment sizes ranged from 150 to 350 nt with a 7-nt minimum separation size between each PCR product were considered in this study. Kanamycin gene (KAN r ) was used as an internal control gene, whilst a house-keeping gene, -actin (ACTB) was used as the normalization gene.
2.1�
. cD�A Synthesis and PC� Ampli�cation. e reverse transcription reactions and PCR ampli�cation were performed according to the GenomeLab GeXP Start Kit using the manufacturer's protocols (Beckman Coulter, USA).
GeXP Multiplex Data
Analysis. e GeXP system was used to separate PCR products based on size by capillary gel electrophoresis and to measure their dye signal strength in arbitrary units of optical �uorescence, de�ned as the �uorescent signal minus background. PCR product sizes were determined using GenomeLab GeXP soware and were compared to the expected PCR product size to identify each transcript. e data were imported into the analysis module of eXpress Pro�ler soware. e housekeeping gene ACTB was used to normalize the results from each gene. e gene expression data were normalized by dividing the peak area of each gene by the peak area of the ACTB gene and the fold change of expression of each gene was calculated using the following formula: fold change = normalized data of the gene from treated samples/normalized data of the gene from untreated samples. e data for each gene and technical replicate were averaged and calculated.
Statistical Analysis.
All data were expressed as means ± SEM of at least three independent experiments. Data were analyzed by ANOVA and Duncan grouping was performed using the SAS system program version 16.0 to identify signi�cant differences between samples. Differences were considered to be signi�cant when . Dose response curves were plotted and the IC50 values (concentrations at which cellular effects are inhibited by 50%) were calculated using a linear regression analysis.
Results
Cell Viability Study (MTT Assay).
Cytotoxic effect of ethanol extract from Chaetoceros calcitrans (EEC) was tested against MCF-7 and MCF-10A cells using colorimetric method MTT assay. Tamoxifen was used as a standard to compare with the EEC tested against MCF-7 cells. Furthermore, the effect of EEC was tested on PBMC to determine the cytotoxicity effect of EEC on human normal peripheral blood mononuclear cells. Bioactivity of EEC was determined based on the concentration that induced 50% inhibition on the growth of the treated cells as compared to the controls in triplicate. MCF-7 and MCF-10A cells were exposed to various concentrations of EEC (0 to 30 g/mL) for 24 and 72 hours. e IC50 values of EEC on MCF-7 and MCF-10A cells were 3 ± 6 and 12 ± 9 g/mL for 24-hour exposure, respectively. A further reduction in IC50 values of EEC was observed aer treatment at 72 hour on MCF-7 and MCF-10A cell lines, 2 69 ± 24 and 3 3 ± 36 g/mL, respectively. e IC50 values of Tamoxifen on MCF-7 cells at 24 and 72 hours were 12 ± 2 and 9 ± 4 g/mL, respectively (Table  2) . Furthermore, EEC did not show cytotoxic effect on PBMC at different concentrations (Table 2) .
Morphological
Study. e EEC treated MCF-7 cells became rounded up, shrunken in size, and detached from the monolayer surface of the wells (Figure 1) . Number of cells was also found decreased when compared to the control and some EEC treated cells showed membrane blebbing and 12.00 ± 0.52 9.00 ± 0.40
Values are expressed as mean ± S.E. from triplicate.
formation of apoptotic bodies which appeared to be round or oval masses of cytoplasm smaller than the original cell.
Annexin V/Propidium Iodide Study.
A signi�cant difference ( 0.001) in viability, early apoptosis, and late apoptosis of MCF-7 cells were detected aer treatment with EEC for 12 hours at IC50 concentration (3.00 g/mL) as compared to the control (Figure 2) . Incubation of MCF-7 with IC50 concentration of EEC aer 12 hour reduced the cell viability to 26.45±0.41% with 31.92±0.48% and 23.98±0.45% of early apoptosis and late apoptosis, respectively. When the EEC concentration was increased to IC75 (4 g/mL), a further reduction in cell viability to 23.99±0.33% with 30.82± 0.31 and 20.23 ± 0.32% of early apoptosis and late apoptosis in MCF-7 cells, respectively, was detected.
A similar reduction in cell viability and increase in apoptotic cells were detected in MCF-7 cells aer EEC incubation for 24 hours. e control untreated cells showed 86.62 ± 0.23%, 8.62 ± 0.19%, and 1.28 ± 0.02% of viability, early apoptosis, and late apoptosis, respectively. However, incubation of MCF-7 with IC50 concentration of EEC aer 24 hours reduced the cell viability to 31.61 ± 0.24% with 49.84 ± 0.47% and 12.63 ± 0.24% of early apoptosis and late apoptosis, respectively (Figure 2 ). In comparison, the higher doses (4 g/mL) of EEC showed 14.05±0.22%, 50.25± 0.55%, and 30.05 ± 0.50% of viability, early apoptosis, and late apoptosis, respectively, in MCF-7 cells aer 24-hour incubation. Only the percentages of viable and late apoptotic between the two different concentrations were signi�cantly different, indicating that increasing the concentration of EEC reduced the viable cells, and increased the number of cells that underwent late apoptosis at 24 hour incubation time. Furthermore, when the proportion of normal and apoptotic cells was scored as a percentage of the total cell population, viable cells decreased from 91% before treatment to less than 26% aer 12 hours and 32% aer 24 hours. Meanwhile the apoptotic cells increased from 0.3% before treatment to 24% and 13% aer 12 and 24 hours of incubation, respectively.
Cell Cycle Analysis.
In cells treated with EEC, a subpopulation of cells appears before the G1 peak is referred to as the subG1 peak. Results indicated that the subG1 population, which indicated apoptotic cells [7] , increased from 0.39% in the control (untreated cells) to 2.31% aer exposure to 3.00 g/mL of the EEC for 24 hours. e subG1 population increased further from 1.62% for the control cells to 55.75% aer exposure to EEC for 48 hours and from 4.53% for the control cells to 72.75% aer exposure to EEC for 72 hour (Table 3) . EEC treated MCF-10A cells also showed similar patterns with a less signi�cant effect where the subG0-G1 population increased from 4.10% in the control to 17.52% aer exposure to 3.00 g/mL of EEC for 24 hours. Similarly, the subG0-G1 population increased from 4.50% in the control cells to 27.24% aer exposure to EEC for 48 hours and also increased from 5% in the control cells to 37.18% aer exposure to EEC for 72 hours (Table 3) .
Gene Expression
Study. e differential expressions of genes in MCF-7 and MCF-10A cells aer treatment were compared with the controls (untreated MCF-7 and MCF-10A cells) and expressed as fold change. As shown in Figure 3 , the fold changes of MDM2 and Cyclin A2 in MCF-7 cells decreased from 1.8 and 3.5 at 6 hours to 1.4 and 1.5 at 24 hours, respectively. Meanwhile, the fold change of p21Cip1 increased from 0.8 at 6 hours to 1.9 at 24 hours. An increase in fold change of proapoptotic gene, Bax, from 1.1 at 6 hours to 1.9 at 24 hours was also detected from the treated MCF-7 cells. In contrast, the fold change of antiapoptotic gene, Bcl-2, decreased from 2.5 at 6 hours to 1.1 at 24 hours. e EEC treated MCF-7 cells also showed a decrease in fold changes of effector caspase, where caspase 3 and caspase 7 in treated MCF-7 decreased from 1.5 and 2.1 at 6 hour to 1.3 and 2.0 at 24 hours, respectively. As shown in Figure 4 , the fold changes of all the genes in MCF-10A cells were not more than 1.0 except for p53 and MDM2 at both time points 6 and 24 hours as well as for p21Cip1, BCL2l1, caspase 3, caspase 7 and caspase 9 at 24 hours. e fold changes of Bax, Bcl-2, p53, Cyclin A2, and CDK2 decreased aer 24-hour incubation time compared to 6 hour samples. Meanwhile, the fold changes for other genes such as p21Cip1, Fas, TNF alpha, MDM2, BCL2L1, caspase 3, 7, and 9 increased at 24-hour incubation time compared to 6 hour samples.
Discussion
In this study, the ethanol extract from Chaetoceros calcitrans (EEC) was extracted and tested on human breast cancer cell lines. In general, EEC showed different IC50 values on the tested cell lines, MCF-7 and MCF-10A at different time points. However, MCF-7 was more responsive to the EEC than MCF-10A with IC50 value of 3.00 ± 0.65. Based on MTT assay, EEC can be considered as potential cytotoxic agent because it showed four fold cytotoxic effect on MCF-7 compared to MCF-10A, with no signi�cant effects on �BMC. is result con�rmed the earlier study that reported on the potential antiproliferative effect of �ve Dunaliella salina ethanol extract on AML cell lines [8] .
Apoptosis, or programmed cell death, is characterized by a number of well-de�ned features which include condensation and fragmentation of the chromatin, internucleosomal DNA cleavage, membrane blebbing, caspase activation, and translocation of phosphatidylserine from the inner to the outer lea�et of the plasma membrane [9] . Hence, induction of apoptosis is one of the useful approaches in cancer therapies [10] . Based on Annexin �/�I and cell cycle �ow cytometry analysis, we found that inhibition of cell growth by EEC on MCF-7 cells is through the induction of apoptosis without cell cycle arrest. In a previous study, the ethanolic extracts of Corallina pilulifera was reported to induce apoptosis in HeLa cells without cell cycle arrest [11, 12] . Even though the EEC treated MCF-10A cells undergo apoptosis, the percentages of apoptotic cells are lower compared to MCF-7 cells. e apoptotic cells at subG0/G1 phase in treated MCF-7 cells at 48 and 72 hours showed 34-and 16-fold increase compared to EEC treated MCF-10A cells which showed only 6-and 7-fold increase at the same time points, respectively. Other study demonstrated that the methanolic extracts of Plocamium telfairiae induce apoptosis in HT-29 human colon carcinoma cells [13] . MCF-10A is a nontumorigenic mammary epithelial cell line [14] . e expression pro�les of apoptotic genes in human breast cancer lines including the normal human breast cell line, MCF-10A cells, have been studied by several investigators [15, 16] . In this study, we analyzed the expression of 13 apoptotic and cell cycle related genes following treatment with EEC on MCF-7 and MCF-10A cells. e expression levels of all the genes in MCF-10A were detected and the majority of them did not show signi�cant variation in gene expression where the lowest and the highest fold changes were 0.4 and 1.3 for CDK2 and p21Cip1, respectively. However, the fold change of MDM2 in EEC treated MCF-7 cells was 1.8 and 1.4 at 6 and 24 hours, respectively ( Figure  3) . Hence, the result supported an earlier study indicating that there is a direct link between MDM2 expression and programmed cell death [17] . Moreover, the fold change of Cyclin A2 expression in MCF-7 cells decreased from 3.5 aer 6 hours of exposure to 1.5 aer 24 hours. Besides that, the fold changes of p21Cip1 in treated MCF-7 cells were 0.8 and 1.9 aer 6 and 24 hours of exposure to EEC, respectively ( Figure 3 ). e function of CDKs is tightly regulated by cell cycle inhibitors like p21Cip1 and p27Kip1 [18] where uncontrolled CDK activity is usually the reason of cancer. p21Cip1 protein binding inhibits the activity of cyclin-CDK2 complexes. is protein was reported to be speci�cally cleaved by caspase 3 like caspases which cause the activation of CDK2 and may be instrumental in the execution of apoptosis following activation. Other studies have shown that the growth inhibitory effect of astaxanthinrich H. pluvialis extract on HCT-116 colon cancer cells was associated with an increase in p21Cip1 expression, cell cycle arrest, and the induction of apoptosis [17] .
Besides that, the fold change of proapoptotic gene, Bax, expression in treated MCF-7 cells for 6 and 24 hour exposed samples was 1.1 and 1.9, respectively ( Figure 3) . Bax gene is a member of the Bcl-2 family, an apoptosis promoter that regulates the release of cytochrome from mitochondria, and its expression is identi�ed to lead to the activation of caspases and programmed cell death [19] . Besides that, an earlier study has shown that the ethanol extract of Dunaliella salina induced apoptosis of A549 human lung cancer cell line by elevating Bax expression [20] . Meanwhile, acetone extract of Lethariella zahlbruckneri increased the expression of the proapoptotic protein, Bax, and decreased the expression of the antiapoptotic protein, Bcl-2 [21] . As shown in Figure 3 , the fold changes of Bcl-2 in MCF-7 cells were 2.5 and 1.1 at 6 and 24 hours, respectively. More importantly, increasing the incubation time from 6 to 24 hours led to the increase of Bax/Bcl-2 ratio, which is an important apoptosis inducer indicator in cancer cells. Our results supported a previous study that demonstrated the inducing of apoptosis of astaxanthin-rich Haematococcus pluvialis extract on HCT-116 colon cancer cells by the increasing of the ratio of Bax/Bcl-2 expression [22] . Overexpressions of Bcl-2 and Bcl-xl have been demonstrated in a large variety of human malignancies, including breast, prostate, colorectal, and lung cancers [23] . e ability of tumour cells to undergo apoptosis by chemotherapeutic agents is controlled by the ratio of Bax/Bcl-2 in the mitochondria [24] . e Bax activation might have involved in the release of cytochrome c from the mitochondria and clustered with APAF-1, an apoptotic protease activating factor 1 and resulted in activation of caspase 9 which then cleaved the downstream caspease 3, 6, and 7 that led to apoptosis [25] . Figure 3 showed upregulation of effectors caspase, caspase 3, and caspase 7 in treated MCF-7 at 6 hour (1.5 and 2.1) and 24 hours (1.3 and 2.0), respectively. Results from this study concur with a previous study that demonstrated chloroform extract of Physalis minima produced a signi�cant growth inhibition and induced apoptosis against human MCF-7 by activation of caspase 3 [14] . us, activation of caspase is recognized to be the most speci�c indication of apoptosis [23] .
Based on the results obtained from this study, it postulates that EEC could induce apoptosis through a caspasedependent pathway by activating caspase 3 and 7 in MCF-7 cells. Hence, Bax activation might have involved in the release of cytochrome c from the mitochondria and probably clustered with APAF-1 and resulted in activation of caspase 9 which then cleaved the downstream caspase 3, 6, and 7 that led to apoptosis. us, this study concluded that the crude ethanol extracts of C. calcitrans has the potential to be used as therapeutic and chemopreventive agents for breast cancer treatment.
